Market leaders Novo Nordisk A/S and Eli Lilly and Company have come to dominate the space through their blockbuster injectable franchises, including Ozempic(R), Wegovy(R), Mounjaro(R) and Zepbound(R)
Prescription Patterns for Sodium-Glucose Cotransporter 2 Inhibitors in U.S
(While Ozempic, which lists the same possible side effects, is the most known GLP-1 drug, its not FDA approved for weight loss generally, which is a common misconception
There are practical, evidence-based strategies you can use to combat nausea while benefiting from GLP-1 medications
This is crucial for weight management because it ensures that blood sugar is efficiently transported into cells for energy rather than remaining in the bloodstream or being poorly synthesized
Some are FDA-approved for weight loss